Indeed, loss of PTPN6 is associated with poor prognosis in hepatocellular carcinoma (HCC), whilst in healthy hepatocytes and HCC cell lines, PTPN6 inhibits the JAK-STAT, nuclear factor (NF)-κB and Akt-dependent signalling pathways [60]. Here, AKT1 is linked to hepatocellular carcinoma.